Work

Robotic gloveless isolator technology enhances regional production of advanced therapeutics

Year: 2025

Type: article

Abstract: The increasing complexity of advanced therapy manufacturing, driven by smaller batch sizes, higher drug substance cost, and stricter regulatory guidelines, necessitates a shift toward more agile and precise production systems. Robotic gloveless isolator (RGI) technology addresses critical challenges in aseptic fill-finish operations by minimizing contamination risk and product loss, particularly for sensitive modalities such as plasmid DNA, viral vectors, mRNA, and recombinant proteins.

Source: Cell and Gene Therapy Insights

DOI: 10.18609/cgti.2025.022

Authors: Zach Hartman, Peter Boman

Language: English

Topic: Protein purification and stability

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Industry, innovation and infrastructure

Open Access status: hybrid

OpenAlex ID: W4417329663

FWCI:

Cites:

Cited by:

Related to: